CYCCP
About this security
CYCCP is a convertible preferred stock issued by Cyclacel Pharmaceuticals Inc 6 Convertible Preferred Stock.
Cyclacel Pharmaceuticals Inc 6 Convertible Preferred Stock: Cyclacel Pharmaceuticals (NASDAQ: CYCC) is a clinical-stage biopharmaceutical company that develops cancer medicines based on cell cycle, epigenetics, and mitosis biology, operating in the United States and the United Kingdom. Its lead programs include fadraciclib, a cyclin-dependent kinase (CDK) inhibitor in Phase 1/2 trials for solid tumors and hematological malignancies, and Plogosertib, a polo-like kinase inhibitor also in Phase 1/2 trials for advanced solid tumors and hematological malignancies. The company is small-cap, with a market capitalization of approximately $13.5 million.
Issuer page — all Cyclacel Pharmaceuticals Inc 6 Convertible Preferred Stock securities & profile →
Key Stats structural terms pending prospectus match
⚠ Liquidation preference not yet confirmed from the prospectus ("par pending"), so premium/discount and yield-to-call are withheld rather than computed from an assumed value. Price, yield, and dividends are exact from the market feed.
Quote
| CYCCP (preferred) | |
|---|---|
| Last | $5.05 |
| Change | +0.00 (+0.00%) |
| Open | $5.05 |
| High / Low | $5.05 / $5.05 |
| Prev Close | $5.05 |
| Volume | — |
| 52-Week High / Low | $5.05 / $5.05 |
52-week range based on available history. Shares outstanding / market cap require a fundamentals feed (not in current data plan).
Price
Dividend History
No recent dividends — distribution may be suspended (check cumulative status) or newly issued.
Performance
See what an investment would be worth today, dividends reinvested. Run the $10K calculator for CYCCP →